AKS-452

Last updated

AKS-452
Vaccine description
Target SARS-CoV-2
Vaccine type Protein subunit
Clinical data
Routes of
administration 		Intramuscular
Identifiers
CAS Number

AKS-452 is a COVID-19 vaccine candidate developed by Akston Biosciences. [2] [3]

References

  1. ↑ "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF).
  2. ↑ "Anti-COVID19 AKS-452 – ACT Study (ACT)". ClinicalTrials.gov . 23 December 2020. NCT04681092. Retrieved 21 March 2021.
  3. ↑ "A study to assess the safety and immunogenicity of Anti-COVID-19 AKS-452 vaccine for SARS-Сov-2 infection in Indian healthy subjects". ctri.nic.in. 11 October 2021. CTRI/2021/10/037269. Retrieved 11 October 2021.


Syringe with Green Fluid.jpg

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.